OS25: Bronchoscopy and Interventional Techniques 1

Identifieur interne : 002726 ( Istex/Corpus ); précédent : 002725; suivant : 002727

---

OS25: Bronchoscopy and Interventional Techniques 1

Auteurs :

Source :

• Respirology [ 1323-7799 ] ; 2013-11.

RBID : ISTEX:785C77229D8131B4CB4FB6625ED494C32681C8E6

English descriptors

• KwdEn :
  • 2department, 2division, 3department, 4department, 5department, 6department, Abnormality, Acute asthma, Acute exacerbation, Adenocarcinoma, Adjuvant chemotherapy, Adult patients, Adverse events, Aerd, Aerd patients, Aichi, Airway, Airway wall area, Aligarh, Allele, Allergen, Allergic, Allergic diseases, Allergic rhinitis, Allergology, Allergy, Amotl1, Amrubicin, Antibiotic, Antimicrobial, Aortic, Apap, Apnea, Apoptosis, April, Ards, Asian, Asian society, Aspergillus, Assay, Asthma, Asthmatic, Asthmatic paecs, Asymptomatic, Atopic, Attenuated, Autoantibody, Autoimmune, Autoimmune pancreatitis, Autophagy, Avium, Bactec, Bactec mgit, Balf, Bangladesh, Baseline, Benign, Bers, Bevacizumab, Biochemistry, Biomarkers, Biomedical, Biopsy, Bleomycin, Body mass index, Brinogen, Brinogen levels, Bronchial asthma, Bronchiectasis, Bronchoalveolar, Bronchoalveolar lavage, Bronchodilation, Bronchodilator, Bronchoscopic, Bronchoscopy, Brosis, Brosis group, Cannabis, Carcinoma, Cardiac, Cell lung cancer, Cell proliferation, Cessation, Changsha, Chemotherapy, China background, Chinese waterpipe, Cigarette smoke, Cipto, Cipto mangunkusumo hospital, Cisplatin, Clinical characteristics, Clinical course, Clinical features, Clinical presentation, Clinical records, Clinical symptoms, Clinician, Clofazimine, Clofazimine therapy group, Cohort, Colonization, Comorbidities, Comorbidity, Control group, Copd, Copd exacerbations, Copd patients, Correlated, Corticosteroid, Cpfe, Critical care, Critical care medicine, Critical role, Crizotinib, Csld, Cyst, Cytokine, December, Dendritic cells, Departement, Desaturation, Diabetes mellitus, Diagnosis, Diagnostic radiology, Diagnostic value, Disease severity, Distal airway, Distinct phenotypes, Dlco, Docetaxel, Drug resistance, Dyspnea, East hanover, Ebtb, Effusion, Egcg, Egfr, Egfr mutation, Egfr mutations, Elderly patients, Elisa, Emergency admission, Emergency department, Emphysema, Empyema, Endobronchial, Endpoint, Environmental health, Epithelial, Epithelial cells, Exacerbation, Exact test, Exon, Expiratory, Expiratory volume, Extracellular, Exudative, Family history, Febrile, Febrile complications, Febrile neutropenia, Feno, Fev1, Foretinib, Foxp3, Fractalkine, Fukuoka, General hospital, Genetic variations, Genotype, Global health, Glycopyrronium, Gnly, Graduate school, Gram staining, Growth factor, Guangdong, Guangzhou, Guideline, Hajime, Hanoi, Hashimoto, Hazard ratio, Hbecs, Health status, Healthy controls, Hematologic, Hematologic malignancies, Hepg2, Hepg2 cells, Hhip, Higher risk, Hiroaki, Hiroshi, Hiroyuki, Histological, Hokkaido, Hokkaido university hospital, Hong kong, Hypertension, Hypoalbuminemia, Hypoxia, Ibaraki, Idiopathic, Idiopathic nsip, Igg4, Igra, Immunosuppressive, Immunosuppressive therapy, Important role, Indacaterol, Indonesia background, Infection, Infectious diseases, Infusion, Inhaled, Inhaler, Inhaler techniques, Initial antimicrobial therapy, Inos, Inos mrna expression, Inspiratory, Intensive care unit, Internal medicine, Interstitial, Interstitial lung disease, Interstitial pneumonia, Ishikawa, Isoniazid, Jakarta, January, Japan, Japan background, Japan introduction, Japanese patients, July, June, Juntendo, Juntendo university graduate school, Kanagawa, Kanazawa, Kazuhisa, Kazuhisa takahashi1, Kazuo, Kentaro, Kinase, Kinki, Kochi, Kyorin, Kyushu, Laba, Lama, Laser, Lavage, Ldem, Lesion, Linezolid, Linezolid therapy group, Lobar emphysema, Logistic regression model, Lowest spo2, Ltc4, Lung, Lung cancer, Lung cancer patients, Lung cancers, Lung disease, Lung diseases, Lung function, Lung tissue, Lymphocyte, Lymphoma, Macitentan, Macrophage, Malignancy, Malignant, Malignant lymphoma, Mangunkusumo, Manoeuvre, Masaharu, Masaki, Median, Median value, Mediastinal, Mediator, Medical center, Medical records, Medical sciences, Medical university, Medication, Medicine, Medicine university, Mellitus, Metastasis, Metastatic, Methods patients, Mgit, Microbiology, Mmhg, Monotherapy, Morbidity, Mortality, Mpap, Mrna, Mrna expression, Msc, Muc5ac, Multicenter, Multivariate, Multivariate analysis, Murine, Murine model, Muscarinic, Mutation, Mycobacterium, Mycobacterium tuberculosis, Nagasaki, Nagoya, Nagoya university graduate school, National center, Nding, Ndings, Negative patients, Neutropenia, Neutrophil, Neutrophilic, Nihon university school, Niigata, Nippv, Nitric, Nitric oxide, Nobuyuki, Node, Nodule, Normal subjects, Nppv, Nsclc, Nsclc patients, Nsip, Obstruction, Obstructive, Occupational exposure, October, Odds ratio, Oncology, Other hand, Overall survival, Oximeter, Paclitaxel, Paecs, Pakistani population, Pancreatitis, Pathogen, Pathogenesis, Pathway, Patient, Patient safety, Pediatric, Pemetrexed, Peripheral blood, Permeability, Persahabatan, Persahabatan hospital, Phenotype, Philippine heart center, Phosphorylation, Placebo, Placebo group, Pleural effusion, Pleural effusions, Plms, Pmdi, Pneumococcal, Pneumonia, Pneumonia cases, Pneumonitis, Pneumothorax, Polygraph, Polymerase chain reaction, Polymorphism, Poor prognosis, Poph, Portable polygraph, Postoperative, Ppfe, Ppls, Predictor, Present study, Previous study, Prognosis, Prognostic, Prognostic factor, Prognostic factors, Prognostic score, Progression, Prospective cohort study, Protein expression, Psoriasis, Pten, Public health, Pulmonary artery pressure, Pulmonary complications, Pulmonary disease, Pulmonary fibrosis, Pulmonary function, Pulmonary function test, Pulmonary hypertension, Pulmonary medicine, Pulmonary tuberculosis, Pulmonology, Pulse oximeter, Quezon, Quezon city, Radiographic, Radiological, Radiology, Randomized, Rassf1a, Reactance, Receptor, Recurrence, Regimen, Relapse, Rescue medication, Research institute, Respiratory, Respiratory center, Respiratory death, Respiratory disease, Respiratory diseases, Respiratory failure, Respiratory hospitalization, Respiratory medicine, Respiratory questionnaire, Respiratory rate, Respirology, Responder, Response rate, Results patients, Retrospective, Retrospectively, Rhinitis, Rifampicin, Risk factors, Rpob gene, Rsbi, Saitama, Salmeterol, Sapporo, Satoshi, Sendai, Seoul, September, Serum levels, Sgrq, Shanghai, Shenyang, Shiga, Singapore, Slipa, Small cell lung cancer, Smear, Smoker, Smoking, Smoking cessation, Smoking history, Smoking status, Snp, Social isolation, Software, Spirometry, Spo2, Sputum, Sputum smear, Standard therapy, Stc1, Stenosis, Stent, Steroid, Subgroup, Subset, Suppl, Surabaya, Surfactant, Surgical, Surgical lung biopsy, Symptom, Syndrome, Taipei, Takahashi1, Takashi, Takeshi, Tapse, Tblb, Terminal stage, Tetsuya, Therapeutic efficacy, Therapy, Thoracic, Thoracic surgery, Thoracoscopy, Thrombocytopenia, Thymoma, Tiotropium, Tissue disorder, Tohoku, Tomography, Toru, Tosei, Toxicity, Tracheal, Traffic policemen, Tranilast, Transbronchial, Treatment difference, Treatment outcome, Tregs, Trough fev1, Tuberculosis, Tumour, Uncontrolled asthma, Univariate, Universitas, Universitas indonesia, University hospital, University school, Urokinase intrathoracic infusion therapy, Varenicline, Vegf, Ventilator, Viral, Wakayama, Wang1, Watanabe1, Waterpipe, Western blot, Wind speed, Xenograft, Xiangya, Xiangya hospital, Yoko, Yokohama, Yoshinori, Yuji, Zinger officinale.
• Teeft :
  • 2department, 2division, 3department, 4department, 5department, 6department, Abnormality, Acute asthma, Acute exacerbation, Adenocarcinoma, Adjuvant chemotherapy, Adult patients, Adverse events, Aerd, Aerd patients, Aichi, Airway, Airway wall area, Aligarh, Allele, Allergen, Allergic, Allergic diseases, Allergic rhinitis, Allergology, Allergy, Amotl1, Amrubicin, Antibiotic, Antimicrobial, Aortic, Apap, Apnea, Apoptosis, April, Ards, Asian, Asian society, Aspergillus, Assay, Asthma, Asthmatic, Asthmatic paecs, Asymptomatic, Atopic, Attenuated, Autoantibody, Autoimmune, Autoimmune pancreatitis, Autophagy, Avium, Bactec, Bactec mgit, Balf, Bangladesh, Baseline, Benign, Bers, Bevacizumab, Biochemistry, Biomarkers, Biomedical, Biopsy, Bleomycin, Body mass index, Brinogen, Brinogen levels, Bronchial asthma, Bronchiectasis, Bronchoalveolar, Bronchoalveolar lavage, Bronchodilation, Bronchodilator, Bronchoscopic, Bronchoscopy, Brosis, Brosis group, Cannabis, Carcinoma, Cardiac, Cell lung cancer, Cell proliferation, Cessation, Changsha, Chemotherapy, China background, Chinese waterpipe, Cigarette smoke, Cipto, Cipto mangunkusumo hospital, Cisplatin, Clinical characteristics, Clinical course, Clinical features, Clinical presentation, Clinical records, Clinical symptoms, Clinician, Clofazimine, Clofazimine therapy group, Cohort, Colonization, Comorbidities, Comorbidity, Control group, Copd, Copd exacerbations, Copd patients, Correlated, Corticosteroid, Cpfe, Critical care, Critical care medicine, Critical role, Crizotinib, Csld, Cyst, Cytokine, December, Dendritic cells, Departement, Desaturation, Diabetes mellitus, Diagnosis, Diagnostic radiology, Diagnostic value, Disease severity, Distal airway, Distinct phenotypes, Dlco, Docetaxel, Drug resistance, Dyspnea, East hanover, Ebtb, Effusion, Egcg, Egfr, Egfr mutation, Egfr mutations, Elderly patients, Elisa, Emergency admission, Emergency department, Emphysema, Empyema, Endobronchial, Endpoint, Environmental health, Epithelial, Epithelial cells, Exacerbation, Exact test, Exon, Expiratory, Expiratory volume, Extracellular, Exudative, Family history, Febrile, Febrile complications, Febrile neutropenia, Feno, Fev1, Foretinib, Foxp3, Fractalkine, Fukuoka, General hospital, Genetic variations, Genotype, Global health, Glycopyrronium, Gnly, Graduate school, Gram staining, Growth factor, Guangdong, Guangzhou, Guideline, Hajime, Hanoi, Hashimoto, Hazard ratio, Hbecs, Health status, Healthy controls, Hematologic, Hematologic malignancies, Hepg2, Hepg2 cells, Hhip, Higher risk, Hiroaki, Hiroshi, Hiroyuki, Histological, Hokkaido, Hokkaido university hospital, Hong kong, Hypertension, Hypoalbuminemia, Hypoxia, Ibaraki, Idiopathic, Idiopathic nsip, Igg4, Igra, Immunosuppressive, Immunosuppressive therapy, Important role, Indacaterol, Indonesia background, Infection, Infectious diseases, Infusion, Inhaled, Inhaler, Inhaler techniques, Initial antimicrobial therapy, Inos, Inos mrna expression, Inspiratory, Intensive care unit, Internal medicine, Interstitial, Interstitial lung disease, Interstitial pneumonia, Ishikawa, Isoniazid, Jakarta, January, Japan, Japan background, Japan introduction, Japanese patients, July, June, Juntendo, Juntendo university graduate school, Kanagawa, Kanazawa, Kazuhisa, Kazuhisa takahashi1, Kazuo, Kentaro, Kinase, Kinki, Kochi, Kyorin, Kyushu, Laba, Lama, Laser, Lavage, Ldem, Lesion, Linezolid, Linezolid therapy group, Lobar emphysema, Logistic regression model, Lowest spo2, Ltc4, Lung, Lung cancer, Lung cancer patients, Lung cancers, Lung disease, Lung diseases, Lung function, Lung tissue, Lymphocyte, Lymphoma, Macitentan, Macrophage, Malignancy, Malignant, Malignant lymphoma, Mangunkusumo, Manoeuvre, Masaharu, Masaki, Median, Median value, Mediastinal, Mediator, Medical center, Medical records, Medical sciences, Medical university, Medication, Medicine, Medicine university, Mellitus, Metastasis, Metastatic, Methods patients, Mgit, Microbiology, Mmhg, Monotherapy, Morbidity, Mortality, Mpap, Mrna, Mrna expression, Msc, Muc5ac, Multicenter, Multivariate, Multivariate analysis, Murine, Murine model, Muscarinic, Mutation, Mycobacterium, Mycobacterium tuberculosis, Nagasaki, Nagoya, Nagoya university graduate school, National center, Nding, Ndings, Negative patients, Neutropenia, Neutrophil, Neutrophilic, Nihon university school, Niigata, Nippv, Nitric, Nitric oxide, Nobuyuki, Node, Nodule, Normal subjects, Nppv, Nsclc, Nsclc patients, Nsip, Obstruction, Obstructive, Occupational exposure, October, Odds ratio, Oncology, Other hand, Overall survival, Oximeter, Paclitaxel, Paecs, Pakistani population, Pancreatitis, Pathogen, Pathogenesis, Pathway, Patient, Patient safety, Pediatric, Pemetrexed, Peripheral blood, Permeability, Persahabatan, Persahabatan hospital, Phenotype, Philippine heart center, Phosphorylation, Placebo, Placebo group, Pleural effusion, Pleural effusions, Plms, Pmdi, Pneumococcal, Pneumonia, Pneumonia cases, Pneumonitis, Pneumothorax, Polygraph, Polymerase chain reaction, Polymorphism, Poor prognosis, Poph, Portable polygraph, Postoperative, Ppfe, Ppls, Predictor, Present study, Previous study, Prognosis, Prognostic, Prognostic factor, Prognostic factors, Prognostic score, Progression, Prospective cohort study, Protein expression, Psoriasis, Pten, Public health, Pulmonary artery pressure, Pulmonary complications, Pulmonary disease, Pulmonary fibrosis, Pulmonary function, Pulmonary function test, Pulmonary hypertension, Pulmonary medicine, Pulmonary tuberculosis, Pulmonology, Pulse oximeter, Quezon, Quezon city, Radiographic, Radiological, Radiology, Randomized, Rassf1a, Reactance, Receptor, Recurrence, Regimen, Relapse, Rescue medication, Research institute, Respiratory, Respiratory center, Respiratory death, Respiratory disease, Respiratory diseases, Respiratory failure, Respiratory hospitalization, Respiratory medicine, Respiratory questionnaire, Respiratory rate, Respirology, Responder, Response rate, Results patients, Retrospective, Retrospectively, Rhinitis, Rifampicin, Risk factors, Rpob gene, Rsbi, Saitama, Salmeterol, Sapporo, Satoshi, Sendai, Seoul, September, Serum levels, Sgrq, Shanghai, Shenyang, Shiga, Singapore, Slipa, Small cell lung cancer, Smear, Smoker, Smoking, Smoking cessation, Smoking history, Smoking status, Snp, Social isolation, Software, Spirometry, Spo2, Sputum, Sputum smear, Standard therapy, Stc1, Stenosis, Stent, Steroid, Subgroup, Subset, Suppl, Surabaya, Surfactant, Surgical, Surgical lung biopsy, Symptom, Syndrome, Taipei, Takahashi1, Takashi, Takeshi, Tapse, Tblb, Terminal stage, Tetsuya, Therapeutic efficacy, Therapy, Thoracic, Thoracic surgery, Thoracoscopy, Thrombocytopenia, Thymoma, Tiotropium, Tissue disorder, Tohoku, Tomography, Toru, Tosei, Toxicity, Tracheal, Traffic policemen, Tranilast, Transbronchial, Treatment difference, Treatment outcome, Tregs, Trough fev1, Tuberculosis, Tumour, Uncontrolled asthma, Univariate, Universitas, Universitas indonesia, University hospital, University school, Urokinase intrathoracic infusion therapy, Varenicline, Vegf, Ventilator, Viral, Wakayama, Wang1, Watanabe1, Waterpipe, Western blot, Wind speed, Xenograft, Xiangya, Xiangya hospital, Yoko, Yokohama, Yoshinori, Yuji, Zinger officinale.

Url:

• https://api.istex.fr/document/785C77229D8131B4CB4FB6625ED494C32681C8E6/fulltext/pdf

DOI: 10.1111/resp.12183_25

---

Links to Exploration step

ISTEX:785C77229D8131B4CB4FB6625ED494C32681C8E6

---

Le document en format XML

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/SidaSubSaharaV1/Data/Istex/Corpus

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002726 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Istex/Corpus/biblio.hfd -nk 002726 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    SidaSubSaharaV1
   |flux=    Istex
   |étape=   Corpus
   |type=    RBID
   |clé=     ISTEX:785C77229D8131B4CB4FB6625ED494C32681C8E6
   |texte=   OS25: Bronchoscopy and Interventional Techniques 1
}}

---

This area was generated with Dilib version V0.6.32. Data generation: Mon Nov 13 19:31:10 2017. Site generation: Wed Mar 6 19:14:32 2024